Compare · ITGR vs NRXS
ITGR vs NRXS
Side-by-side comparison of Integer Holdings Corporation (ITGR) and Neuraxis Inc. (NRXS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ITGR and NRXS operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- ITGR is the larger of the two at $4.26B, about 56.2x NRXS ($75.8M).
- Over the past year, ITGR is up 15.4% and NRXS is up 149.6% - NRXS leads by 134.2 points.
- ITGR has been more active in the news (16 items in the past 4 weeks vs 14 for NRXS).
- ITGR has more recent analyst coverage (23 ratings vs 0 for NRXS).
- Company
- Integer Holdings Corporation
- Neuraxis Inc.
- Price
- $125.38+0.38%
- $6.09+0.58%
- Market cap
- $4.26B
- $75.8M
- 1M return
- +26.04%
- -10.31%
- 1Y return
- +15.36%
- +149.59%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NYSE
- AMEX
- IPO
- 2023
- News (4w)
- 16
- 14
- Recent ratings
- 23
- 0
Integer Holdings Corporation
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and management systems, charging and docking stations, and power supplies for the energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Latest ITGR
- SEC Form DEFA14A filed by Integer Holdings Corporation
- INTEGER HOLDINGS: Kaskela Law Announces Probe into Adequacy of $127.00 Per Share Buyout Price – Fair or Inadequately Low for the Company’s Shareholders?
- SEC Form 10-Q filed by Integer Holdings Corporation
- SEC Form DEFA14A filed by Integer Holdings Corporation
- Integer Holdings Corporation filed SEC Form 8-K: Financial Statements and Exhibits
- SEC Form DEFA14A filed by Integer Holdings Corporation
- SEC Form DEFA14A filed by Integer Holdings Corporation
- SEC Form DEFA14A filed by Integer Holdings Corporation
- SEC Form DEFA14A filed by Integer Holdings Corporation
- SEC Form DEFA14A filed by Integer Holdings Corporation
Latest NRXS
- Neuraxis Inc. filed SEC Form 8-K: Leadership Update, Other Events
- Director Watkins Bradley Mitchell was granted 26,073 shares, increasing direct ownership by 56% to 72,408 units (SEC Form 4)
- SEC Form 4 filed by CMO, SVP Science & Tech Miranda Adrian
- Director Keyser Jane Elizabeth was granted 26,073 shares, increasing direct ownership by 56% to 72,408 units (SEC Form 4)
- SEC Form 4 filed by Chief Financial Officer Henrichs Timothy Robert
- Director Ferge Kristin A was granted 31,134 shares, increasing direct ownership by 87% to 67,072 units (SEC Form 4)
- SEC Form 4 filed by CRO, CCO, CPO Carrico Thomas Joeseph
- SEC Form 4 filed by Chief Executive Officer Carrico Brian Allen
- Director Aharon Gil was granted 86,224 shares, increasing direct ownership by 136% to 80,058 units (SEC Form 4)
- NeurAxis Reports Record Second Quarter 2026 Financial Results Driven by 116% Year Over Year Revenue Growth